US Patent Issued to Sanegene Bio USA on Aug. 11 for "Small interfering RNA targeting C3 and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,865, issued on Aug. 11, was assigned to Sanegene Bio USA Inc. (Woburn, Mass.).

"Small interfering RNA targeting C3 and uses thereof" was invented by Chunyang Zhang (Burlington, Mass.), Xin Geng (Belmont, Mass.), Shiyu Wang (Belmont, Mass.) and Weimin Wang (Winchester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to isolated oligonucleotides comprising duplex regions targeting human complement C3 mRNA, and delivery systems, kits and compositions comprising the same, and methods of using the same for inhibiting or downregulating C3 gene expression."

The patent was filed on April 30, 2024, under Application No. 18/650,7...